» Articles » PMID: 12711360

The Role of the CD44/ezrin Complex in Cancer Metastasis

Overview
Specialty Hematology
Date 2003 Apr 25
PMID 12711360
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

CD44 is a cell adhesion molecule that was traditionally known as 'homing receptor'. This molecule is known to interact with the ezrin family (ERM family) members and form a complex that plays diverse roles within both normal and abnormal cells, particularly cancer cells. CD44 and ezrin and their respective complex have properties suggesting that they may be important in the process of tumour-endothelium interactions, cell migrations, cell adhesion, tumour progression and metastasis. This article reviews the role of CD44, ezrin family and the CD44/ezrin complex in cancer cells and their clinical impact in patients with cancer.

Citing Articles

Identification of CD44 as a key engager to hyaluronic acid-rich extracellular matrices for cell traction force generation and tumor invasion in 3D.

Cheung B, Chen X, Davis H, Nordmann C, Toth J, Hodgson L Matrix Biol. 2024; 135():1-11.

PMID: 39528207 PMC: 11729355. DOI: 10.1016/j.matbio.2024.11.004.


ARHGAP18-ezrin functions as an autoregulatory module for RhoA in the assembly of distinct actin-based structures.

Lombardo A, Mitchell C, Zaman R, McDermitt D, Bretscher A Elife. 2024; 13.

PMID: 38193818 PMC: 10830128. DOI: 10.7554/eLife.83526.


Ezrin Inhibition Overcomes Acquired Resistance to Vemurafenib in BRAFV600E-Mutated Colon Cancer and Melanoma Cells In Vitro.

Car I, Dittmann A, Vasieva O, Bockor L, Grbcic P, Pitesa N Int J Mol Sci. 2023; 24(16).

PMID: 37629086 PMC: 10454476. DOI: 10.3390/ijms241612906.


Ez-Metastasizing: The Crucial Roles of Ezrin in Metastasis.

Buenaventura R, Merlino G, Yu Y Cells. 2023; 12(12).

PMID: 37371090 PMC: 10297006. DOI: 10.3390/cells12121620.


Amino acid profile changes during enrichment of spheroid cells with cancer stem cell properties in MCF-7 and MDA-MB-231 cell lines.

Movahed Z, Matin M, Mansouri K, Sisakhtnezhad S Cancer Rep (Hoboken). 2023; 6(5):e1809.

PMID: 37092500 PMC: 10172158. DOI: 10.1002/cnr2.1809.